R. Bansal

Ruchi obtained her Bachelor’s and Master’s degree in Biochemistry from Delhi University, India. In 2012, She obtained her PhD from the Department of Pharmacokinetics, Toxicology and Targeting, University of Groningen. Her PhD project was focused on designing of novel strategies to target interferon gamma and its signaling domain to the target pathogenic cells in the chronic diseases (liver fibrosis and cancer). During the last stages of her PhD, she received two prestigious grants Sheila Sherlock research fellowship (from European association for the study of liver diseases, EASL) and The Ruth and Richard Julin’s Foundation Swedish research grant for postdoctoral research at the Karolinska Institute, Stockholm, Sweden. Her research project was focused on “Pathogenesis of Hepatitis C virus (HCV)-induced and alcohol-induced liver diseases”. In October 2012, she started as a senior postdoctoral researcher at the Department of Biomaterials Science and Technology at the University of Twente. In 2014, she received the prestigious VENI grant (from NWO, ZonMw) to pursue her research on “Development of novel targeted nano-therapeutics for the treatment of liver diseases”. She has received several awards and research grants for pursuing her research. Since 2016, she is appointed as an Assistant professor and has established her independent research group "Translational Liver Research" at the Department of Medical Cell BioPhysics, the University of Twente.